Literature DB >> 31125460

Characterization of the novel cardiolipin binding regions identified on the protease and lipid activated PKC-related kinase 1.

Jason L J Lin1.   

Abstract

Protein kinase C-related kinase 1 (PRK1) or PKN is a protease and lipid activated protein kinase that acted downstream of the RhoA or Rac1 pathway. PRK1 comprises a unique regulatory domain and a PKC homologous kinase domain. The regulatory domain of PRK1 consists of homologous region -1 (HR1) and -2 (HR2). PRK1-(HR1) features a pseudosubstrate motif that overlapped with the putative cardiolipin and known RhoA binding sites. In fact, cardiolipin is the most potent lipid activator for PRK1 in respect of its either auto- or substrate phosphorylation activity. This study was thus aimed to characterize the binding region(s) of cardiolipin that was previously suggested for the regulatory domain of PRK1. The principal findings of this work established (i) PRK1-(HR1) folded into an active conformation where high affinity binding sites (mainly located in HR1a subdomain) were accessible for cardiolipin binding to protect against limited Lys-C digestion, (ii) the binding nature between acidic phospholipids and PRK1 (HR1) involved both polar and nonpolar components consistent with the amphipathic nature of the known cardiolipin-binding motifs, (iii) identification of the molecule masses of the Lys-C fragments of PRK1-(HR1) complexed with cardiolipin molecule, and (iv) appreciable reductions in the secondary structural contents at 222 nm measured by circular dichroism analyses demonstrated the binding of cardiolipin elicited the disruptive effect that was most evident among all phospholipids tested, suggestive of a functional correlation between the extents of helical disruption and PRK1 activation.
© 2019 The Protein Society.

Entities:  

Keywords:  Lys-C or endo Lys-C; MALDI-TOF MS; PKN; PRK1; cardiolipin; heptad repeats; phosphatidic acid; phosphatidylcholine; phosphatidylserine

Mesh:

Substances:

Year:  2019        PMID: 31125460      PMCID: PMC6635769          DOI: 10.1002/pro.3663

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  38 in total

Review 1.  Theoretical aspects of the quantitative characterization of ligand binding.

Authors:  W H Sawyer; D J Winzor
Journal:  Curr Protoc Protein Sci       Date:  2001-05

2.  The structural basis of Rho effector recognition revealed by the crystal structure of human RhoA complexed with the effector domain of PKN/PRK1.

Authors:  R Maesaki; K Ihara; T Shimizu; S Kuroda; K Kaibuchi; T Hakoshima
Journal:  Mol Cell       Date:  1999-11       Impact factor: 17.970

3.  Expression, purification and characterization of the ubiquitous protein kinase C-related kinase 1.

Authors:  R H Palmer; P J Parker
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

4.  The role of the unique motifs in the amino-terminal region of PKN on its enzymatic activity.

Authors:  M Kitagawa; H Shibata; M Toshimori; H Mukai; Y Ono
Journal:  Biochem Biophys Res Commun       Date:  1996-03-27       Impact factor: 3.575

5.  Purification and characterization of a fatty acid-activated protein kinase (PKN) from rat testis.

Authors:  M Kitagawa; H Mukai; H Shibata; Y Ono
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

6.  Phosphorylation events associated with different states of activation of a hepatic cardiolipin/protease-activated protein kinase. Structural identity to the protein kinase N-type protein kinases.

Authors:  B Peng; N A Morrice; L C Groenen; R E Wettenhall
Journal:  J Biol Chem       Date:  1996-12-13       Impact factor: 5.157

7.  Vital role of protein kinase C-related kinase in the formation and stability of neurites during hypoxia.

Authors:  Bettina Thauerer; Stephanie zur Nedden; Gabriele Baier-Bitterlich
Journal:  J Neurochem       Date:  2010-01-28       Impact factor: 5.372

Review 8.  The structure and function of PKN, a protein kinase having a catalytic domain homologous to that of PKC.

Authors:  Hideyuki Mukai
Journal:  J Biochem       Date:  2003-01       Impact factor: 3.387

9.  Development of an intracellularly acting inhibitory peptide selective for PKN.

Authors:  Kazuhiro Shiga; Kentaro Takayama; Shiroh Futaki; Jessica E Hutti; Lewis C Cantley; Katsuko Ueki; Yoshitaka Ono; Hideyuki Mukai
Journal:  Biochem J       Date:  2009-12-23       Impact factor: 3.857

10.  Accumulation of phosphatidylalcohol in cultured cells: use of subcellular fractionation to investigate phospholipase D activity during signal transduction.

Authors:  Y S Edwards; A W Murray
Journal:  Biochem J       Date:  1995-06-01       Impact factor: 3.857

View more
  2 in total

1.  The effects of cardiolipin on the structural dynamics of the mitochondrial ADP/ATP carrier in its cytosol-open state.

Authors:  Qiuzi Yi; Shihao Yao; Boyuan Ma; Xiaohui Cang
Journal:  J Lipid Res       Date:  2022-05-12       Impact factor: 6.676

Review 2.  The structure and function of protein kinase C-related kinases (PRKs).

Authors:  Georgios Sophocleous; Darerca Owen; Helen R Mott
Journal:  Biochem Soc Trans       Date:  2021-02-26       Impact factor: 5.407

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.